Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat
Cited by 625

The DOI matches its Crossref record; 20 of the 20 references it cites were found in a registry or an index.

Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients

Niu, Chao, Yan, Hua, Yu, Ting, Sun, Hui-Ping, Liu, Jian-Xiang, Li, Xiu-Song, Wu, Wen, Zhang, Fen-Qin, Chen, Yu, Zhou, Li, Li, Jun-Min, Zeng, Xiao-Ying, Yang, Ren-Rong Ou, Yuan, Mi-Man, Ren, Mei-Yu, Gu, Feng-Ying, Cao, Qi, Gu, Bo-Wei, Su, Xin-Ying, Chen, Guo-Qiang, Xiong, Shu-Min, Zhang, Ting-dong, Waxman, Samuel, Wang, Zhen-Yi, Chen, Zhu, Hu, Jiong, Shen, Zhi-Xiang, Chen, Sai-Juan · 1999 · Blood

Abstract

Fifty-eight acute promyelocytic leukemia (APL) patients (11 newly diagnosed and 47 relapsed) were studied for arsenic trioxide (As2O3) treatment. Clinical complete remission (CR) was obtained in 8 of 11 (72.7%) newly diagnosed cases. However, As2O3 treatment resulted in hepatic toxicity in 7 cases including 2 deaths, in contrast to the mild liver dysfunction in one third of the relapsed patients. Forty of forty-seven (85.1%) relapsed patients achieved CR. Two of three nonresponders showed clonal evolution at relapse, with disappearance of t(15;17) and PML-RAR fusion gene in 1 and shift to a dominant AML-1-ETO population in another, suggesting a correlation between PML-RAR expression and therapeutic response. In a follow-up of 33 relapsed cases over 7 to 48 months, the estimated disease-free survival (DFS) rates for 1 and 2 years were 63.6% and 41.6%, respectively, and the actual median DFS was 17 months. Patients with white blood cell (WBC) count below 10 × 109/L at relapse had better survival than those with WBC count over 10 × 109/L (P = .038). The duration of As2O3-induced CR was related to postremission therapy, because there was only 2 of 11 relapses in patients treated with As2O3 combined with chemotherapy, compared with 12 of 18 relapses with As2O3 alone (P = .01). Reverse transcription polymerase chain reaction (RT-PCR) analysis in both newly diagnosed and relapsed groups showed long-term use of As2O3 could lead to a molecular remission in some patients. We thus recommend that ATRA be used as first choice for remission induction in newly diagnosed APL cases, whereas As2O3 can be either used as a rescue for relapsed cases or included into multidrug consolidation/maintenance clinical trials.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1182/blood.v94.10.3315.422k16_3315_3324

Cites

20 of 20 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 20 references

Cited by

See all 625

Metadata

Authors
Niu, C., Yan, H., Yu, T., Sun, H.-P., Liu, J.-X., Li, X.-S., Wu, W., Zhang, F.-Q., Chen, Y., Zhou, L., Li, J.-M., Zeng, X.-Y., Yang, R.-R. O., Yuan, M.-M., Ren, M.-Y., Gu, F.-Y., Cao, Q., Gu, B.-W., Su, X.-Y., Chen, G.-Q., Xiong, S.-M., Zhang, T.-D., Waxman, S., Wang, Z.-Y., Chen, Z., Hu, J., Shen, Z.-X., & Chen, S.-J.
Venue
Blood
Published
1999-11-15
Volume
94
Issue
10
Pages
3315-3324
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W2128291738
Cited by
625
References
20
FWCI
9.79
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients. https://app.cochat.ai/papers/10.1182/blood.v94.10.3315.422k16_3315_3324
The paper
Niu, C., Yan, H., Yu, T., Sun, H.-P., Liu, J.-X., Li, X.-S., Wu, W., Zhang, F.-Q., Chen, Y., Zhou, L., Li, J.-M., Zeng, X.-Y., Yang, R.-R. O., Yuan, M.-M., Ren, M.-Y., Gu, F.-Y., Cao, Q., Gu, B.-W., Su, X.-Y., . . . Chen, S.-J. (1999). Studies on Treatment of Acute Promyelocytic Leukemia With Arsenic Trioxide: Remission Induction, Follow-Up, and Molecular Monitoring in 11 Newly Diagnosed and 47 Relapsed Acute Promyelocytic Leukemia Patients. Blood. https://doi.org/10.1182/blood.v94.10.3315.422k16_3315_3324

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.